Illumina Closes $400M Note Sale After Adding $50M Over-Allotment | GenomeWeb
NEW YORK (GenomeWeb News) — Illumina today said it has closed the sale of $400 million in convertible senior notes.
 
The company on Monday said it would sell $325 million in notes to pay for corporate expenses, but on Tuesday it raised the offering to $350 million.
 
The sale at closing included the exercise of an over-allotment for an additional $50 million of notes, bringing the total to $400 million.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.